APP and Alzheimer disease: Studies in APP/PS1 transgenic mouse models (TMMs) have consistently demonstrated significant reductions in sulfatides (SHexCers) and glycerophosphoinositols (GroPIns) in the cerebral cortex, hippocampus, and cerebellum, indicating both aging- and AD-related neurodegeneration [59].